A study to compare the efficacy of nanobiofusion gel in the treatment of chronic periodontitis in smokers and non-smokers: A randomized controlled trial
Phase 4
- Conditions
- Health Condition 1: K053- Chronic periodontitis
- Registration Number
- CTRI/2024/04/065484
- Lead Sponsor
- Dr Leanne Braganca
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1-Systemically healthy participants.
2-Age group: 20–65 years.
3-A minimum of twenty teeth present.
4-Probing pocket depth (PPD) of 5-6mm in two contralateral quadrants.
5-Smoker’s Group: Moderate smokers- 6-10 cigarettes/day & Heavy smokers (More than 11 cigarettes per day)
(Jones et al, 2011)
Exclusion Criteria
1-Systemically compromised patients.
2-Patients taking any other medications.
3-Patients with known allergies or hypersensitivity reactions.
4-Pregnant and lactating women.
5-Subjects who underwent periodontal treatment within a period of 6 months.
6-History of antibiotic intake at least 3 months prior.
7-History of use of mouthwashes within 4 weeks before the start of the study.
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in probing depthTimepoint: baseline and 3 months
- Secondary Outcome Measures
Name Time Method Reduction in microbial load of P gingivalis based on number of colony forming unitsTimepoint: baseline and 6 weeks